瑞替普酶静脉溶栓与PCI治疗急性心肌梗死的疗效对比OA
Effect Comparison of Reteplase Intravenous Thrombolysis and Percutaneous Coronary Intervention in Treatment of Acute Myocardial Infarction
目的：比较瑞替普酶静脉溶栓与经皮冠状动脉介入（PCI)治疗急性心肌梗死的临床效果。方法回顾性分析81例急性心肌梗死患者的临床资料，按照治疗方法的不同分为PCI组（41例)和瑞替普酶静脉溶栓组（40例)，对比两组患者的预后情况和不良心血管事件发生情况。结果溶栓组患者接受血运重建的时间比PCI组更及时（P<0.05)，但溶栓组患者CK-MB峰值比PCI组高，出血程度和恶性心律失常发作程度比PCI组严重， LVEF值比PCI组低（P<0.0…查看全部>>
Objective To compare the clinical efficacy of reteplase intravenous thrombolysis and percutaneous coronary intervention (PCI) in treatment of acute myocardial infarction (AMI). Methods The clinical data of 81 AMI patients were retrospectively analyzed. All patients were divided into two groups according to different treatment methods:PCI group (41 cases), reteplase intravenous thrombolysis group (40 cases). The prognosis conditions and adverse cardiovascular…查看全部>>
黄丹丹;廖成标;乐建华;张惠琪;蒋爱忠
广东省河源市人民医院心内科，广东河源517000广东省河源市人民医院心内科，广东河源517000广东省河源市人民医院心内科，广东河源517000广东省河源市人民医院心内科，广东河源517000广东省河源市人民医院心内科，广东河源517000
医药卫生
急性心肌梗死急诊PCI瑞替普酶
Acute myocardial infarctionEmergency PCIReteplase
《临床医学工程》 2016 (4)
483-484,2
评论